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Single nucleotide polymorphisms (SNPs) within the MIR137, TCF4, and ZNF804A genes show genome-wide
association to schizophrenia. However, the biological basis for the associations is unknown. Here, we tested
the effects of these genes on brain structure in 1300 healthy adults. Using volumetry and voxel-based
morphometry, neither gene-wide effects—including the combined effect of the genes—nor single SNP effects—in-
cluding speciﬁc psychosis risk SNPs—were found on total brain volume, grey matter, white matter, or
hippocampal volume. These results suggest that the associations between these risk genes and schizophrenia
are unlikely to be mediated via effects on macroscopic brain structure.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
A recent meta-analysis of GWAS studies of schizophrenia found the
strongest evidence for an association with the single nucleotide
polymorphism (SNP) rs1625579 in an intron of the MIR137 (http://
www.genecards.org/cgi-bin/carddisp.pl?gene=mir137) gene (Ripke
et al., 2011). This association was later replicated in a GWAS study,
providing increasing evidence for a role for MIR137 in the aetiology
of schizophrenia (Ripke et al., 2013). Interestingly, MIR137, which en-
codes amicroRNA, regulates several other schizophrenia risk genes, no-
tably ZNF804A (http://www.genecards.org/cgi-bin/carddisp.pl?gene=
ZNF804A) and TCF4 (http://www.genecards.org/cgi-bin/carddisp.pl?
gene=TCF4) (Kim et al., 2012; Guella et al., 2013; Kwon et al., 2013;
Wright et al., 2013). In silico, cellular, and luciferase based approaches
have provided evidence that MIR137 downregulates both ZNF804A
(Kim et al., 2012) and TCF4 (Guella et al., 2013; Kwon et al., 2013)
expression.
DNA sequence variation in ZNF804A and TCF4 has been robustly
associated with schizophrenia risk. SNP rs1344706, in intron two of
ZNF804A, was the ﬁrst variant to reach unequivocal genome-wide
signiﬁcance for schizophrenia (O'Donovan et al., 2008), with a later
meta-analysis conﬁrming the association and extending it to a broader
psychosis phenotype (Williams et al., 2011). For TCF4, Stefansson et al.
(2009) ﬁrst reported an association between SNP rs9960767, in intron
3 of the gene, and schizophrenia, with several other SNPs in the gene
subsequently being associated with the disorder (Ripke et al., 2011;
Steinberg et al., 2011). ZNF804A and TCF4 are believed to encode tran-
scription factors, but little is known about the mechanistic pathways
via which they might increase risk for schizophrenia. Similarly, the
risk SNPs are located in non-coding regions of the genes and it is not
yet clear how they modulate disease risk. At the molecular level, they
may impact on transcript expression or splicing (Hill and Bray, 2012;
Guella et al., 2013; Tao et al., 2014); at the systems level, the risk alleles
may inﬂuence brain function or structure (Esslinger et al., 2009;
Quednow et al., 2011; Rasetti et al., 2011; van Erp et al., 2014).
Structural MRI studies show that schizophrenia is associated with a
reduction in total brain volume of around 2.6%, with larger effects for
grey matter than white matter, and with the reductions prominent in
frontal and temporal cortices and hippocampus (Fornito et al., 2009;
Ellison-Wright and Bullmore, 2010; Haijma et al., 2013). For the SNPs
under investigation in this study, only SNP rs1625579 in the MIR137
genehas been associatedwith smaller hippocampal volumes in patients
with schizophrenia (Lett et al., 2013). Therefore, we focused our
investigations on total brain volume, grey matter, white matter, and
hippocampal volume only.
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Given the unambiguous genetic epidemiological evidence for the in-
volvement of these three genes in the risk of schizophrenia, we investi-
gated whether allelic variation in these genes impacts on macroscopic
brain structure in a cohort of 1300 healthy adults. We assessed single
SNP as well as gene-wide effects on our volumes of interest. We also in-
vestigated the joint effect of these three genes on these brain volumes
(given the regulatory effects of MIR137 on ZNF804A and TCF4 (Wright
et al., 2013)). Additionally, using voxel-based morphometry (VBM),
we studied whether risk SNPs rs1344706 in ZNF804A, rs9960767 in
TCF4, and rs1625579 in MIR137 were associated with variation in grey
and white matter volume.
2. Methods
This study is part of the Brain Imaging Genetics (BIG) project which
comprises healthy volunteer subjects, mostly university students, who
participate in diverse imaging studies at the Donders Centre for Cogni-
tive Neuroimaging (DCCN), Nijmegen, The Netherlands (Franke et al.,
2010; Stein et al., 2012). At the time of this study, anatomical (T1-
weighted) MRI scans and genetic data were available from 1300 self-
reported healthy subjects, usually as part of their involvement in diverse
smaller-scale studies at the DCCN. All had given their consent to partic-
ipate in BIG. Demographic information about the cohort can be found in
Table 1. The studywas approved by the regionalmedical ethics commit-
tee (CMO Arnhem-Nijmegen).
Genetic analyses, including genotyping, genetic imputation and
quality control were performed as described previously (Guadalupe
et al., 2014). Three different genes, MIR137, TCF4, and ZNF804A and
approximately 25 kilobase ﬂanking regions were analysed. A total
of 1211 SNPs were included in the analysis (168 for MIR137, 146 for
TCF4, and 897 for ZNF804A).
Magnetic resonance imaging (MRI) data were acquired at the
Donders Centre for Cognitive Neuroimaging at 1.5T and 3T Siemens
MRI scanners. Data acquisition and analysis have been described pre-
viously (Franke et al., 2010; Cousijn et al., 2012).
Statistical analysis on the volumetric datawas performed using the –
linear command implemented in PLINK software V1.07 (http://pngu.
mgh.harvard.edu/~purcell/plink/) (Purcell et al., 2007). The method of
analysis we performed was analogous to the method reported by
Bralten et al. (2011, 2013) and Cousijn et al. (2012). The analysis
consisted of a SNP-by-SNP linear regression and the estimation of the
effect of the complete gene. Additionally, we assessed the effect of the
three genes combined. The SNP-by-SNP linear regression for association
with brain volumes (GM,WM, TBV and hippocampal volume) was per-
formed using sex, age, and TBV as covariates. The analysis of GMwas ad-
justed by WM volume and vice-versa. Multiple testing correction was
performed by running 10,000 max(T) permutation tests using the
“mperm” command and obtaining an empirical p-value for each SNP.
The association statistics of the observed and permuted data were
saved using the “mperm-save-all” command and then added to create
a Σstatistic per run for all SNPs at the same time (10,001 in total, one
for the observed data and 10,000 for the permuted data). The empirical
p-value was then estimated by the number of times the observed
Σstatistic was bigger than the permuted Σstatistic divided by the total
number of permutations (10,000). Results were considered signiﬁcant
at p b 0.05.
Additionally, VBM analyses were carried out for the schizophrenia
risk SNPs rs1344706 in ZNF804A, rs9960767 in TCF4, and rs1625579 in
MIR137. We also included in this analysis any other SNP showing signif-
icant association (empirical p-value corrected for multiple testing) with
any of the volumes. A full-factorial ANCOVA with these SNPs as factor
and participants' age, gender, TBV (where appropriate), and scan proto-
col as covariates was carried out. Statistics were corrected for non-
stationarity and were applied at p(whole brain uncorrected) b .001
and subsequent cluster statistics at p(FWE) b .05. A Bonferroni correc-
tion was applied to correct for multiple comparisons.
3. Results
The gene-wide analysis of the individual genes as well as the three
genes combined did not yield any signiﬁcant results for association
with TBV, GM volume, WM volume, or hippocampal volume (Table 2).
In the SNP-by-SNP analysis, one SNP in MIR137, rs9440302, was
found to have a signiﬁcant association with hippocampal volume
(Supplementary Fig. 1), with an empirical p-value of 0.0166 (pemp was
estimated adjusting for 168 SNPs). Therefore, this SNPwas also included
in the VBM analysis). We looked speciﬁcally at the effects of SNPs
rs1344706 in ZNF804A, rs9960767 in TCF4, and rs1625579 in MIR137
on GM, WM, TBV and hippocampal volume but no signiﬁcant effects
were detected for these risk SNPs. The corrected p-values from the
SNP-by-SNP analysis for these risk SNPs can be found in Supplementary
Table 1. Corrected and uncorrected p-values for all studied SNPs can be
found in Supplementary Table 2. When excluding left-handed subjects
from our analyses, we found the same results.
Whole-brain VBM analyses revealed no effect of SNPs rs1344706 in
ZNF804A, rs9960767 in TCF4, and rs1625579 inMIR137 on GM or WM
volumes. For SNP rs9440302 in MIR137, whole-brain analyses as well
as a region of interest analysis within a hippocampal ROI (WFU
pickatlas, Tzourio-Mazoyer et al., 2002) showed no effects.
4. Discussion
Here we studied the effects of schizophrenia risk genes MIR137,
TCF4, and ZNF804A on macroscopic brain variation in healthy volun-
teers. No gene-wide effects or effects of speciﬁc risk SNPs were found
on greymatter, white matter, total brain volume, and hippocampal vol-
ume. Additionally, when looking at the combined effect of the three risk
genes, no effects could be detected. Given the large sample size used in
this study (power to detect an effect size ≥ 5% with n = 1300; a SNP
MAF = 19%; D′ = 0.5 with the causal variant; α= 0.05 is 80%), these
ﬁndings provide convincing evidence that SNPs in these genes do not
impact on macroscopic brain structure in young healthy volunteers.
This is the ﬁrst study, to our knowledge, assessing the effects of SNPs
in TCF4 on TBV, GM, WM, and hippocampal volume. We also extended
and replicated our earlier ﬁnding that variation in ZNF804A does not
affect these parameters (increasing our sample size 46%: n = 892 vs
n = 1300 see Cousijn et al., 2012; also Bergmann et al., 2013;
Sprooten et al., 2012). Regarding MIR137, SNP rs1625579 has been
previously associated with smaller hippocampal volumes in patients
with schizophrenia (Lett et al., 2013), but we did not observe this effect
Table 1
Demographic information, volumes in ml.
Total N 1300
Mean age (years) 22.9 (3.8)
Sex F/M 57.4/42.6%
Handedness (R) 93.6%
Mean TBV (SD) 1257.8 (125.5)
Mean GM volume (SD) 775.1 (81.4)
Mean WM volume (SD) 482.7 (62.1)
Mean Hippocampus volume (SD) 4.0 (0.4)
Table 2
Gene-wide p-values for the three genes separately and combined.
TBV GM WM Hippocampus
ZNF804A 0.4666 0.7560 0.9986 0.3868
MIR137 0.9271 0.8644 0.9971 0.1552
TCF4 0.9419 0.3158 0.4460 0.7306
All three genes combined 0.5543 0.8287 0.9089 0.3502
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in our sample of healthy controls. We did observe an association
between SNP rs9440302 within MIR137 and hippocampal volume,
with the A allele being associated with larger hippocampal volumes.
However, we could not replicate this ﬁnding using VBM, so future stud-
ies are needed to determine whether this is a robust association. More-
over, this SNP has not been associated with risk for schizophrenia and
we found the probability of an association between this SNP and risk
SNP rs1625579 to be very low (r2 = 0.203), indicating that they pro-
bably work independently.
Genetic neuroimaging studies in healthy volunteers provide impor-
tant information about potential pathways between genetic variation
and schizophrenia, by investigating the effects of risk genes on brain
structure or brain function unconfounded by effects of the illness or its
treatment. In this study,we have shown that genetic variation in schizo-
phrenia risk genes MIR137, TCF4, and ZNF804A does not lead to alter-
ations in TBV, GM, WM, or hippocampal brain volumes as measured
with structural MRI in healthy young adults. Whilst we cannot rule
out that effects might be found using different imaging methods such
as diffusion tensor imaging, or that there might be effects in clinical
populations or neurodevelopmental effects in childhood, it seems
more likely that the pathophysiological correlates of allelic variation in
these genes occur in other ways, such as via modulation of brain func-
tion or functional connectivity.
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